4.3 Article

Phase II, randomized, multicenter, comparative study of peginterferon-alpha-2a (40 kD) (Pegasys (R)) versus interferon alpha-2a (Roferon (R)-A) in patients with treatment-naive, chronic-phase chronic myelogenous leukemia

评价这篇论文

主要评分表示论文的整体质量水平。次要评分独立反映论文的优点或缺点。

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started